Additional Collaboration Sample Clauses

Additional Collaboration. Novatel Wireless and Intel will engage in the following technical collaboration:
Sample 1Sample 2
AutoNDA by SimpleDocs
Additional Collaboration. Within [***] after the Effective Date, the Parties will discuss the [***].
Sample 1Sample 2
Additional Collaboration. If Producer wishes to terminate any Author, such Author shall retain any and all amounts paid, or due and payable, by Producer to such Author hereunder at the time of such termination. Notwithstanding anything to the contrary herein, each Author acknowledges that the Film is an established story, and that, inevitably, different individuals approaching the material contained in the Film may develop such material in ways that are similar, and even in some cases identical, to such Author’s development of material hereunder. Such Author further acknowledges and agrees that Producer and Owner are entitled to discuss the Film with third parties and obtain third party ideas and suggestions for developing material related thereto, and if Producer or Owner ultimately uses material that is the same as or similar to material which such Author creates, such Author shall not be entitled to any compensation or credit except in the limited situation in which the original material created by such Author hereunder rises to the level of being separately protectable under the United States Copyright Act of 1976 (as amended), taking into account material owned by the Owner (including, without limitation, the Film), material provided to such Author by other authors of or contributions to the Play, material provided to such Author by Producer, material in the public domain, scènes à faire and similar doctrines, and any other defense that would be available in a copyright infringement litigation. If such Author alleges that any such separately protectable material has been used and Producer agrees with such allegation, Producer and such Author shall negotiate in good faith to determine an appropriate payment and attribution, but in the event of a disagreement either as to liability or compensation, the arbitration provisions of paragraph 19 below shall apply and, without limiting the generality of the foregoing or the other provisions of paragraph 19 below, such Author, and anyone claiming by, through or under such Author, shall not be entitled to equitable relief, whether injunctive or otherwise, in connection with the use of any such separately protectable materials. In any event, Producer shall be entitled to continue with the development of the Play during negotiations and/or the pendency of any dispute with such Author being replaced.
Sample 1
Additional Collaboration. Upon execution of this MOU, individual institutions of NSHE may separately collaborate with the Secretary of Education in Tamaulipas, as well as Tamaulipas colleges and universities, to further develop and implement institution-specific programs and enter into agreements consistent with the intent, scope, and terms of this MOU.
Sample 1
Additional Collaboration. ARTICLE IIEach Party shall promptly provide to the other Party all data, materials and other information, and shall promptly take all such other actions, as may be reasonably requested by the other Party from time to time in order to perform its obligations hereunder and comply with all Laws applicable to the matters addressed in this Agreement. ARTICLE IIIEach Party shall cooperate with the other Party’s reasonable requests in responding to or resolving any complaint, investigation, inquiry or review initiated by a governmental agency, or otherwise relating to the Product or the services provided by either Party as described in this Agreement. Each Party shall cooperate with the reasonable request of any insurance company providing protection to either Party in connection with the foregoing.
Sample 1
Additional Collaboration. The Parties shall exercise good-faith negotiations to enter into a separate collaboration aimed at the further development and commercialization of one or more therapeutics encompassing or employing an siRNA that is deliverable to the posterior pole of the eye which may be administered by systemic application for pharmaceutical use in humans (the “Systemic siRNA”). The financial terms of the Systemic siRNA collaboration shall be consistent with and substantially similar to the provisions of Sections 7.1, 7.3, 7.4, 7.5 and 7.6(a) of this Agreement, after taking into account and considering the relevant market for the Systemic siRNA and its expected commercial success.
Sample 1

Related to Additional Collaboration

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Development Schedule The Project shall substantially comply with the specific timetables and triggers for action set forth in Article 5 of this Agreement. The parties acknowledge that, as provided in G.S. 160A-400.25(b), the failure to meet a commencement or completion date shall not, in and of itself, constitute a material breach of this Agreement pursuant to G.S. 160A-400.27 but must be judged based upon the totality of the circumstances.

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Research Program 2.1 University will use reasonable efforts to conduct the Research Program described in Attachment A which is hereby incorporated in full by reference (“Research Program”), and will furnish the facilities necessary to carry out said Research Program. The Research Program will be under the direction of _____________________ (“Principal Investigator”), or his or her successor as mutually agreed to by the Parties and will be con­ducted by the Principal Investigator at the University.

Time is Money Join Law Insider Premium to draft better contracts faster.